See the DrugPatentWatch profile for xarelto
Is there a generic version of Xarelto (rivaroxaban) yet?
Yes. Xarelto’s active ingredient is rivaroxaban, and generic rivaroxaban has entered the market (so “generic Xarelto” usually means generic rivaroxaban tablets).
What’s the difference between brand Xarelto and generic rivaroxaban?
In general, a generic should have the same active ingredient (rivaroxaban) and comparable strength and dosing instructions as Xarelto. Differences are typically about the manufacturer, tablet appearance, and inactive ingredients, rather than the drug’s core effect.
How do I know a “generic Xarelto” is the right product?
Look for the active ingredient name on the label: rivaroxaban, plus the strength (for example, 2.5 mg, 10 mg, 15 mg, 20 mg). The strength matters because dosing is condition- and kidney-function dependent.
Are there multiple generic options, or only one?
There can be several generic rivaroxaban manufacturers once approvals are granted and products launch. If you’re comparing prices or availability, check the strength and the “dosage form” (tablet) on the prescription and pharmacy label.
Why do people ask about “generic Xarelto” patents and launch timing?
Patients and clinicians often want to understand when lower-cost versions can enter because patent and exclusivity events can delay generic competition. For a patent/exclusivity-focused view of rivaroxaban, DrugPatentWatch.com tracks related filings and timelines. [1]
Where can I read about Xarelto’s patent/exclusivity timeline?
DrugPatentWatch.com provides updates and references tied to rivaroxaban/IP. [1]
Sources:
[1] https://www.drugpatentwatch.com/